Drugmakers’ Secret Weapon To Keep Your Meds Overpriced
Big drugmakers are abusing the drug patent process to generate extra revenue at the cost of patients, according to a new report.
Business
Critical coverage on the global financial system and domestic policies that shape the U.S. economy, with a focus on corporate wrongdoing.
War Is Peace, Gas Is Now “Clean Energy”
Secretive dark money groups are pushing states to redefine methane gas, undermining renewable energy initiatives.
YOU LOVE TO SEE IT: Geostalkers Get Lost
Geolocation data is safe and sound, new parents get a break, one city’s road to reparations, and sports betting giants need to pay up.
Wall Street To Insurers: Keep Denying Care
UnitedHealth Group’s investors were profiting from its high denial rates. Now, they’re suing to ensure that doesn’t change.
Big Tech’s Monopoly Money
Lawmakers are about to let tech giants issue their own currency — what could go wrong?
Crypto’s New Bailout Fund: Your Savings Account
The GENIUS Act would require banks to prioritize stablecoin owners over customers if there’s a financial collapse.
A Chilean Billionaire Strikes Gold In The Budget Bill
The budget reconciliation bill includes an environmentally devastating natural resources giveaway to a Chilean billionaire with close ties to the Trump family.
Tesla’s Great Shareholder Muzzling Of 2025
As Tesla’s sales collapse, Trump’s financial regulators just let Elon Musk’s vehicle company block nearly all shareholder proposals, including on union efforts and climate goals.
Get Ready To Pay In ZuckBucks
The GENIUS Act isn’t just a crypto giveaway — it could turn tech giants into unregulated banks.
The Pharma Puppets Keeping Your Drug Prices High
Six supposed patient advocacy groups are closely linked to drugmakers and pushing industry-aligned agendas, according to a new report.